Loading insider details...
Beta
Latest Form 4 (Jul 30, 2026): Grant/Award of 31,667 VKTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 31,667 | n/a |
| Jan 6, 2026 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 41,000 | n/a |
| Oct 28, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 11,117 | n/a |
| Jul 3, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 7,667 | n/a |
| Jan 7, 2025 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 44,533 | n/a |
| Oct 29, 2024 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 12,750 | $99.1K |
| Jul 31, 2024 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 6,667 | n/a |
| May 4, 2024 | Viking Therapeutics, Inc. (VKTX) | Exercise/Conversion | 4,249 | $19.9K |
| Mar 28, 2024 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 31,667 | n/a |
| Mar 5, 2024 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 31,667 | n/a |